Venture Capital Investors

Abingworth

Abingworth is a VC investing group that backs high-potential tech companies.

Venture Investor Overview

Venture Investor
Abingworth
Status
Active
Activity Level
Industry Focus
Biopharmaceutical

Contact Information

Contact
Stephen Bunting
Title
Managing Partner
Mailing Address
3000 Sand Hill Road B1 - 145
Menlo Park, CA 94025
USA
Email Address
Not Recorded

Background Information

Overview
Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. We invest across all stages of company development including early and late-stage venture financing, growth equity and public companies
Profile
Abingworth LinkedIn Company Profile
Social Media
Abingworth Company Twitter Account
Company News
Abingworth News
Facebook
Abingworth on Facebook
YouTube
Abingworth on YouTube
Last Transaction
9/9/2021

Transaction History

Our records indicate that Abingworth invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
9/9/2021
$135,000,000
6/24/2021
$68,000,000
4/19/2021
$18,000,000
1/22/2021
$80,000,000
1/8/2021
$162,000,000
12/17/2020
$55,000,000
12/10/2020
$95,000,000
10/27/2020
$108,000,000
5/29/2020
$46,000,000
3/27/2020
$110,000,000
2/21/2020
$88,000,000
12/10/2019
$35,000,000
12/3/2019
$55,500,000
5/16/2019
$140,000,000
1/4/2019
$75,000,000
7/21/2018
$4,000,000
6/8/2018
$85,000,000
5/1/2018
$35,000,000
7/26/2017
$42,000,000
7/25/2017
$38,600,000
3/22/2017
$64,000,000
6/23/2016
$27,000,000
3/8/2016
$43,000,000
12/3/2015
$28,420,000
7/24/2015
$22,000,000
7/22/2015
$43,000,000
4/30/2015
$64,000,000
2/27/2015
$70,000,000
1/13/2015
$33,000,000
9/30/2014
$4,180,000
5/16/2014
$45,000,000
4/17/2014
$40,000,000
10/7/2013
$22,000,000
9/30/2013
$501,900
8/1/2013
$60,000,000
5/21/2013
$45,000,000
3/6/2013
$43,000,000
2/20/2013
$21,000,000
7/24/2012
$38,500,000
5/15/2012
$25,000,000
3/29/2012
$65,000,000
9/30/2011
$5,007,000
9/12/2011
$150,000,000
6/30/2011
$12,000,000
10/6/2010
$30,000,000
8/11/2010
$25,000,000
5/5/2010
$40,000,000
12/31/2009
$65,635,000
9/23/2009
$51,000,000
9/21/2009
$20,000,000
7/27/2009
$30,000,000
6/30/2009
$146,300,000
3/16/2009
$45,000,000
1/16/2009
$22,000,000
12/31/2008
$9,999,800
9/30/2008
$39,999,700
9/5/2008
$20,000,000
3/31/2008
$3,808,800
3/13/2008
$17,016,100
1/9/2008
$18,000,000
1/8/2008
$21,000,000
12/31/2007
$12,400,000
12/31/2007
$16,983,900
12/13/2007
$44,000,000
8/20/2007
Unknown
5/7/2007
$70,000,000
3/31/2007
$9,986,000
1/25/2007
$16,500,000
1/5/2007
$32,500,000
12/31/2006
$6,000,000
11/28/2006
$50,000,000
9/30/2006
$29,500,000
8/23/2006
$50,000,000
6/30/2006
$30,000,100
4/27/2006
$65,000,000
4/3/2006
$53,000,000
3/31/2006
$2,499,900
2/23/2006
$45,000,000
11/29/2005
$7,000,000
11/8/2005
$46,000,000
11/7/2005
$25,000,000
11/2/2005
$30,000,000
8/25/2005
$23,000,000
7/25/2005
$21,000,000
5/23/2005
$59,800,000
3/31/2005
$5,040,000
9/27/2004
$14,400,000
6/14/2004
$18,914,200
5/17/2004
$34,500,000
4/6/2004
$30,000,000
1/12/2004
$18,875,000
12/18/2003
$27,000,000
12/8/2003
$21,000,000
7/10/2003
$22,000,000
4/3/2003
$22,500,000

 


Investor Contacts

Title
Name
Email & Social
Partner
Joseph Anderson
  Joseph Anderson LinkedIn Profile  Joseph Anderson Twitter Account  Joseph Anderson News  Joseph Anderson on Facebook
Partner
Michael Bigham
  Michael Bigham LinkedIn Profile  Michael Bigham Twitter Account  Michael Bigham News  Michael Bigham on Facebook
Managing Partner
Stephen Bunting
  Stephen Bunting LinkedIn Profile  Stephen Bunting Twitter Account  Stephen Bunting News  Stephen Bunting on Facebook
Partner
Shelley Chu
  Shelley Chu LinkedIn Profile  Shelley Chu Twitter Account  Shelley Chu News  Shelley Chu on Facebook
Principal
Michelle Doig
  Michelle Doig LinkedIn Profile  Michelle Doig Twitter Account  Michelle Doig News  Michelle Doig on Facebook
Partner
Brian Gallagher
  Brian Gallagher LinkedIn Profile  Brian Gallagher Twitter Account  Brian Gallagher News  Brian Gallagher on Facebook
Partner
Ken Haas
  Ken Haas LinkedIn Profile  Ken Haas Twitter Account  Ken Haas News  Ken Haas on Facebook
Partner
Timothy Haines
  Timothy Haines LinkedIn Profile  Timothy Haines Twitter Account  Timothy Haines News  Timothy Haines on Facebook
Partner
Vincent Miles
  Vincent Miles LinkedIn Profile  Vincent Miles Twitter Account  Vincent Miles News  Vincent Miles on Facebook
Principal
John Shields
  John Shields LinkedIn Profile  John Shields Twitter Account  John Shields News  John Shields on Facebook
Partner
Kurt von Emster
  Kurt von Emster LinkedIn Profile  Kurt von Emster Twitter Account  Kurt von Emster News  Kurt von Emster on Facebook

 


Funds

Our database includes the following fund closing(s) for Abingworth. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Abingworth Bioventures VII
7/9/2018
$315,000,000
Abingworth Clinical Co-Development Fund
1/21/2016
$105,000,000
Abingworth Bioventures VI
10/9/2013
$375,000,000

 


Portfolio Companies

Abingworth has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more venture capital investors:

Abies Ventures | Able Partners

 

Share this article

 


About Our Venture Capital Investor Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary